Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen
- PMID: 19874205
- PMCID: PMC4100544
- DOI: 10.1086/647945
Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen
Abstract
Background: Chronic granulomatous disease (CGD) is a rare inherited disease of the phagocyte NADPH oxidase system that causes defective production of toxic oxygen metabolites, impaired bacterial and fungal killing, and recurrent life-threatening infections, mostly by catalase-producing organisms. We report for the first time, to our knowledge, chronic infections with Actinomyces species in 10 patients with CGD. Actinomycosis is a chronic granulomatous condition that commonly manifests as cervicofacial, pulmonary, or abdominal disease, caused by slowly progressive infection with oral and gastrointestinal commensal Actinomyces species. Treatment of actinomycosis is usually simple in immunocompetent individuals, requiring long-term, high-dose intravenous penicillin, but is more complicated in those with CGD because of delayed diagnosis and an increased risk of chronic invasive or debilitating disease.
Methods: Actinomyces was identified by culture, staining, 16S ribosomal DNA polymerase chain reaction, and/or a complement fixation test in 10 patients with CGD.
Results: All 10 patients presented with a history of fever and elevated inflammatory signs without evident focus. Diagnosis was delayed and clinical course severe and protracted despite high-dose intravenous antibiotic therapy and/or surgery. These results suggest an unrecognized and unanticipated susceptibility to weakly pathogenic Actinomyces species in patients with CGD because these are catalase-negative organisms previously thought to be nonpathogenic in CGD.
Conclusions: Actinomycosis should be vigorously sought and promptly treated in patients with CGD presenting with uncommon and prolonged clinical signs of infection. Actinomycosis is a catalase-negative infection important to consider in CGD.
Conflict of interest statement
Figures
Comment in
-
Chronic granulomatous disease, catalase, and Actinomyces.Clin Infect Dis. 2010 May 1;50(9):1325; author reply 1325-6. doi: 10.1086/651690. Clin Infect Dis. 2010. PMID: 20367233 No abstract available.
References
-
- Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000;79:170–200. - PubMed
-
- Winkelstein JA, Marino MC, Johnston RB, Jr, et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine (Baltimore) 2000;79:155–169. - PubMed
-
- Brailsford SR, Lynch E, Beighton D. The isolation of Actinomyces naeslundii from sound root surfaces and root carious lesions. Caries Res. 1998;32:100–106. - PubMed
